ALPHA-SYNUCLEIN ERKENNENDE HUMANISIERTE ANTIKÖRPER

European patent · EP2807188 · Deleted

Register entry

Publication number
EP2807188
Application number
EP13740871
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 25, 2013
Published
Dec 3, 2014
Granted
Sep 11, 2019
Deleted
Aug 24, 2022
Reason
Annual fee unpaid
IPC classes
C07K 16/18 (2006.01)
A61K 39/00 (2006.01)
A61K 49/00 (2006.01)
A61K 49/16 (2006.01)
A61K 51/10 (2006.01)
Priority
US 201261591835 P 27.01.2012
US 201261711207 P 08.10.2012
PCT application
PCT/US2013/023307 25.01.2013
PCT publication
WO2013/112945 01.08.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 24, 2022

    Deleted, fee unpaid

    Published in Swissreg on 24.08.2022

  2. May 16, 2022

    Address changed

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 16.05.2022

  3. Dec 14, 2019

    Agent entered

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich

    Published in Swissreg on 14.12.2019

  4. Sep 11, 2019

    Granted

    Published in Swissreg on 11.09.2019

Parties

Holder

Prothena Biosciences Limited

77 Sir Rogerson's Quay Block C Grand Canal Docklands, Dublin 2, D02 T804, IE

Agent

RENTSCH PARTNER AG

Kirchenweg 8 Postfach, 8034 Zürich

Inventor

SALDANHA, Jose

Enfield EN1 3BD, GB

NIJJAR, Tarlochan S.

Orinda California 94563, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.